Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter

NCT ID: NCT05710458

Last Updated: 2023-02-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-01

Study Completion Date

2022-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective randomised controlled trial will be conducted to investigate that increasing the vitrectomy cutting rate from 10,000 cut/min to 20,000 cut/min will result more efficiency and shorter core vitrectomy time, and it is equally safe as compared to the current 10,000 cut/min. We plan to target the patients undergoing for vitrectomy for common vitreoretinal pathology. Our plan is to conduct a randomised study with 2 arms, one with the higher cutting rate (20,000 cut/min) versus a second arm using the existing system 10,000 cuts/min.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In addition, we will measure the core vitrectomy duration by Constellation Vision System stopwatch. We will count the duration when the vitrectomy probe enter into the eye to the moment the performing the air/fluid exchange by shaving the peripheral vitreous to complete the vitrectomy. For our second outcome measure to prove the no-inferiority of intraoperative and postoperative complications patients will have 3 months follow up visits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vitrectomy Epiretinal Membrane Macular Hole Vitreous Hemorrhage Retinal Detachment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Patients are randomised and masked from the treatment

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

25 gauge 20,000 cpm Hypervit Dual Blade

New vitrectomy blade with higher cutting rate

Group Type EXPERIMENTAL

25 gauge 20,000 cpm Hypervit Dual Blade

Intervention Type DEVICE

Vitrectomy blade with increased cutting rate to 20,000 cut/min

25 gauge 10,000 Ultravit vitrectomy cutter

Existing vitrectomy blade with cutting rate 10,000 cut/min

Group Type ACTIVE_COMPARATOR

25 gauge 10,000 cpm Ultravit Vitrectomy Cutter

Intervention Type DEVICE

Existing Vitrectomy blade with cutting rate 10,000 cut/min

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

25 gauge 20,000 cpm Hypervit Dual Blade

Vitrectomy blade with increased cutting rate to 20,000 cut/min

Intervention Type DEVICE

25 gauge 10,000 cpm Ultravit Vitrectomy Cutter

Existing Vitrectomy blade with cutting rate 10,000 cut/min

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

20K 10K

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over 18 years of age who are undergoing vitrectomy for the following conditions:

* Macular hole
* Epimacular membrane
* Vitreous hemorrhage
* Primary retinal detachment

Exclusion Criteria

* Patient who is

* unable to give proper consent
* previous vitrectomy or scleral buckle surgery
* cases requiring silicone oil tamponed
* undergoing repeated retinal detachment surgery
* undergoing surgery for tractional diabetic retinopathy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Nicholas Fung

Clinical Asst Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Grantham Hospital

Hong Kong, , Hong Kong

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

References

Explore related publications, articles, or registry entries linked to this study.

O'Malley C, Heintz RM Sr. Vitrectomy with an alternative instrument system. Ann Ophthalmol. 1975 Apr;7(4):585-8, 591-4.

Reference Type BACKGROUND
PMID: 1147502 (View on PubMed)

Rizzo S, Genovesi-Ebert F, Belting C. Comparative study between a standard 25-gauge vitrectomy system and a new ultrahigh-speed 25-gauge system with duty cycle control in the treatment of various vitreoretinal diseases. Retina. 2011 Nov;31(10):2007-13. doi: 10.1097/IAE.0b013e318213623a.

Reference Type BACKGROUND
PMID: 21685823 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20K

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Choroidal Thickness Vitrectomy
NCT02617147 COMPLETED